Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 12,517 | N/A |
| TOTAL | $12,529 | $N/A |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $12,529 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 57 | 0 |
| Accrued Expenses | 17 | N/A |
| Other current liabilities | 2,600 | N/A |
| TOTAL | $2,674 | $N/A |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 3 | 0 |
| TOTAL | $3 | $N/A |
| Total Liabilities | $2,677 | $N/A |
| Shareholders' Equity | ||
| Retained earnings | -161 | N/A |
| Other shareholders' equity | 10,011 | 0 |
| TOTAL | $9,852 | $N/A |
| Total Liabilities And Equity | $12,529 | $0 |